347 filings
ARS
2023 FY
STOK
Stoke Therapeutics Inc
23 Apr 24
Annual report to shareholders
4:11pm
DEFA14A
STOK
Stoke Therapeutics Inc
23 Apr 24
Additional proxy soliciting materials
4:08pm
DEF 14A
STOK
Stoke Therapeutics Inc
Definitive proxy
23 Apr 24
4:06pm
SC 13D/A
Skorpios Trust
18 Apr 24
Stoke Therapeutics / Skorpios Trust ownership change
4:18pm
4
Skorpios Trust
18 Apr 24
Change in insider ownership
4:16pm
144
2o7en994mz9zgiwo5nfo
17 Apr 24
Notice of proposed sale of securities
4:17pm
S-8
xkexac1bi8j2fts
11 Apr 24
Registration of securities for employees
4:06pm
4
vvl6j
3 Apr 24
Stoke Therapeutics / Barry Ticho ownership change
4:21pm
4
9hzykr38j967v da6f
3 Apr 24
Stoke Therapeutics / Huw M. Nash ownership change
4:19pm
144
cxdrr9z nrz
1 Apr 24
Notice of proposed sale of securities
4:36pm
144
mm2yrjf
1 Apr 24
Notice of proposed sale of securities
4:25pm
4
zkc1topn7hc7jfm qr
1 Apr 24
Stoke Therapeutics / Jonathan Allan ownership change
4:14pm
8-K
uvhcofn6henu27qd0rd
28 Mar 24
Stoke Therapeutics Announces Pricing of Upsized $125 Million Public Offering
5:20pm
424B5
3jyqxf1rf1 zmb7
28 Mar 24
Prospectus supplement for primary offering
5:15pm
144
p8thznkh2g6zlgjaw
28 Mar 24
Notice of proposed sale of securities
4:38pm
FWP
6599drwx8it rdl
27 Mar 24
Free writing prospectus
6:25pm
424B5
ikwxkcx5bhmcnwcz63t
26 Mar 24
Prospectus supplement for primary offering
4:47pm
8-K
n17rulr 0ox3axpdh
25 Mar 24
Stoke Therapeutics Announces Landmark New Data That Support the Potential for STK-001
4:07pm
8-K
uwjo1g
25 Mar 24
Stoke Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
4:03pm